Somatic mutation analysis revealed that 19.41% of the HCC samples had ERG gene mutations, but the mutation frequency of individual genes was relatively low (e.g., POLQ: 4%, ATAD2: 2%) (Figure 2B). This evidence concerns the gene ATAD2 and hepatocellular carcinoma.